Forbes
@forbes·2.1M subscribers·11.3K videos
How Europe’s Mixed Messages On AstraZeneca Could Jeopardize The Global Covid Response | Forbes
Posted
March 25, 2021
Views
6,691
Likes
63
Comments
14
Engagement
1.15%
March 25, 2021
6,691
63
14
1.15%
Every word spoken in this episode is indexed. Type any phrase to jump straight to the moment it was said.
Type any word or phrase that may have been spoken. Click a result to seek the player to that exact moment.
Try a name, a topic, or a quoted line
3:25Now PlayingIn March, more than a dozen European countries suspended use of AstraZeneca’s COVID-19 vaccine because of concerns over blood clotting.
AstraZenica has said the clotting is not related to the vaccine. And while the WHO and European Medicines Agency are both conducting additional reviews of the vaccine, they said countries should not have suspended use of the vaccine. Experts are worried these steps could erode people’s willingness to get the vaccine.
Largely due to an inadequate supply of doses, The European Union has lagged behind other countries in terms of the vaccine rollout, with fewer than 11.4 vaccinations for every 100 people as of March. By comparison, the U.S. has 32.6 vaccinations per hundred people, and the U.K. leads the pack with 38.4 per hundred.
This kind of fear could have global implications if enough people choose not to get vaccinated.
Read the full profile on Forbes
Subscribe to FORBES
Stay Connected
Forbes newsletters
Forbes on Facebook
Forbes Video on Twitter
Forbes Video on Instagram
More From Forbes
Forbes covers the intersection of entrepreneurship, wealth, technology, business and lifestyle with a focus on people and success.
Sentinel Indexing in Progress
Metadata and chapters are available. Claim extraction for this episode is pending.
All video content is delivered via YouTube embedded players in accordance with the YouTube Terms of Service. Sentinel provides research tools that promote discovery and accountability across political media.
